ABOUT
INVESTORS
NEWS
CONTACT

ABOUT
INVESTORS
NEWS
CONTACT

Linkedin Facebook-f Instagram

NEWS

Doseology Raises $4,451,568 and Files Preliminary Non-offering Prospectus.

May 13, 2021

Page1 Page2 Page3 Page4 Page5

FOR NEWS UPDATES

Join our mailing list

Doseology Sciences is a performance-driven innovation company at the intersection of biotechnology and advanced delivery systems, engineering precision-formulated oral stimulants that optimize energy, focus, and cognitive performance.

Quick Links

ABOUT
INVESTORS
NEWS
CONTACT

ABOUT
INVESTORS
NEWS
CONTACT

Shop

Feed That Brain™

Get In Touch

Suite 3059 – 3151 Lakeshore Road, Kelowna, British Columbia, V1W 3S9

E: investor@doseology.com

LEGAL DISCLAIMER

© 2025 All Rights Reserved.

Linkedin Facebook-f Instagram

Receive our latest news directly in your inbox!

Join Our Email

Your email

I agree to receive investor updates and communications from Doseology Sciences Inc. You can unsubscribe at any time by clicking the link in the footer of our emails. For more information about how we handle your data, please review our Privacy Policy or contact us at hello@doseology.com.